Business Description
Universal Ibogaine Inc
NAICS : 541713
SIC : 3741
ISIN : CA91360F1099
Compare
Compare
Traded in other countries / regions
IBO.CanadaJC4.GermanyIBOGF.USA IPO Date
2022-02-25Description
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | 0.29 | |||||
| Debt-to-Equity | 1.78 | |||||
| Debt-to-EBITDA | -2.55 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -7 | |||||
| Beneish M-Score | -0.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -26 | |||||
| 3-Year EPS without NRI Growth Rate | -21.6 | |||||
| 3-Year FCF Growth Rate | 7.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.08 | |||||
| 9-Day RSI | 53.83 | |||||
| 14-Day RSI | 52.88 | |||||
| 6-1 Month Momentum % | -11.11 | |||||
| 12-1 Month Momentum % | 300 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.65 | |||||
| Quick Ratio | 0.65 | |||||
| Cash Ratio | 0.42 | |||||
| Days Sales Outstanding | 35.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -158 | |||||
| Shareholder Yield % | -63.49 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -34.86 | |||||
| Net Margin % | -66.94 | |||||
| FCF Margin % | -35.23 | |||||
| ROE % | -87.53 | |||||
| ROA % | -28.05 | |||||
| ROIC % | -13.33 | |||||
| ROC (Joel Greenblatt) % | -38.97 | |||||
| ROCE % | -37.92 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.91 | |||||
| PB Ratio | 2 | |||||
| EV-to-EBIT | -4.88 | |||||
| EV-to-EBITDA | -6.38 | |||||
| EV-to-Revenue | 2.97 | |||||
| EV-to-FCF | -6.55 | |||||
| Earnings Yield (Greenblatt) % | -20.49 | |||||
| FCF Yield % | -17.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Universal Ibogaine Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.598 | ||
| EPS (TTM) (€) | -0.004 | ||
| Beta | 0 | ||
| Volatility % | 957.89 | ||
| 14-Day RSI | 52.88 | ||
| 14-Day ATR (€) | 0.001735 | ||
| 20-Day SMA (€) | 0.004375 | ||
| 12-1 Month Momentum % | 300 | ||
| 52-Week Range (€) | 0.0005 - 0.0245 | ||
| Shares Outstanding (Mil) | 308.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Universal Ibogaine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Universal Ibogaine Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Universal Ibogaine Inc Frequently Asked Questions
What is Universal Ibogaine Inc(FRA:JC4)'s stock price today?
The current price of FRA:JC4 is €0.01. The 52 week high of FRA:JC4 is €0.02 and 52 week low is €0.00.
When is next earnings date of Universal Ibogaine Inc(FRA:JC4)?
The next earnings date of Universal Ibogaine Inc(FRA:JC4) is .
Does Universal Ibogaine Inc(FRA:JC4) pay dividends? If so, how much?
Universal Ibogaine Inc(FRA:JC4) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers